What's new

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 11, Status: Authorised

Jun 2, 2025 - 19:00
 0
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

STAT+: UnitedHealth conducting ‘comprehensive review’ of Medicare practices that...

Next Article

Human medicines European public assessment report (EPAR): Tecartus, brexucabtage...

Related Posts

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion

Opinion on medicine for use outside EU: Mosquirix, RTS,...

May 18, 2025  0

CAT quarterly highlights and approved ATMPs - May 2025

Jun 2, 2025  0